Maxim Biomedical, Inc
UnclaimedIn-Vitro Diagnostic Substance ManufacturingRockville, MD
Founded
2005
Primary NAICS
325413
CAGE code
4EJW3
Federal awards
$106.9M
Classification
This U.S. industry comprises establishments primarily engaged in manufacturing in-vitro (i.e., not taken internally) diagnostic substances, such as chemical, biological, or radioactive substances. The substances are used for diagnostic tests that are performed in test tubes, petri dishes, machines, and other diagnostic test-type devices.
- Manufacturing32
- Chemical Manufacturing325
- Pharmaceutical and Medicine Manufacturing32541
- In-Vitro Diagnostic Substance Manufacturing325413
Capabilities
Biological Product (except Diagnostic) ManufacturingAnalytical Laboratory Instrument ManufacturingOther Measuring and Controlling Device Manufacturing
Federal awards
| Year | Agency | Obligated | Actions |
|---|---|---|---|
| 2026 | Department of Defense | $155,000 | 1 |
| 2025 | Department of Health and Human Services | $0 | 1 |
| 2024 | Department of Health and Human Services | -$80,100 | 6 |
| 2023 | Department of Health and Human Services | $52,236,000 | 2 |
| 2022 | Department of Defense | $54,640,000 | 3 |
| 2022 | Department of Health and Human Services | -$51,465 | 4 |